Navigation Links
Cellular Biomedicine Group Announces Positive Interim Results from Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)
Date:9/6/2013

PALO ALTO, Calif., Sept. 6, 2013 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today announced the interim results of its Phase I/IIa clinical trial for human adipose-derived mesenchymal precursor cell (haMPC) therapy for Knee Osteoarthritis (KOA), which tests the safety and efficacy of intra-articular injections of autologous (patient's own) haMPCs in order to reduce inflammation and repair damaged joint cartilage. On schedule for completion in Q4 2013, the interim analysis of the trial has preliminarily demonstrated a significant improvement (P<0.05) from the baseline in clinical scores for SF-36, NRS-11, and WOMAC osteoarthritis indices, and no serious adverse events have been reported.

"We are very pleased with the results of the trial thus far and we look forward to the full data readout before the end of the year," said Wei (William) Cao, PhD, BM, President at Cellular Biomedicine Group. "Knee osteoarthritis severely impacts one's quality of life, and surgical treatment is very costly and invasive. This trial's preliminary results have encouraged us to continue with the study to further test the efficacy of this hopeful therapy to reduce pain, repair knee cartilage and improve quality of life of the patients in the next Phase II trial."

Knee Osteoarthritis in China
There are approximately 57 million people in China suffering from knee osteoarthritis. As drug-based methods of management are ineffective, many patients with this disease will degenerate to the point of requiring invasive artificial joint replacement surgery.

About the Clinical Trial
Cellular Biomedicine Group's Phase I/IIa clinical trial studies the safety and efficacy of CBMG's proprietary adipose-derived progenitor cell (haMPC) - based therapy for knee osteoarthritis. According to the interim analysis of Phase I/IIa for KOA, 24 patie
'/>"/>

SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cellular Dynamics Launches MyCell™ Services
2. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
3. CeeTox and Cellular Dynamics Collaborate to Offer Predictive In Vitro Test for Cardiotoxicity Using Human iPSC-derived Cells
4. EastBridge Investment Group Announces Merger with Cellular Biomedicine Group
5. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
6. Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
7. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
8. Cellular Dynamics Announces Presentations at the Society of Toxicologys 52nd Annual Meeting Demonstrating the Expanding Impact of iPSC-Derived Human Cells on Toxicology Assay Development
9. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
10. Cellular Dynamics International Opens Facility in California, Leasing Space from the Buck Institute to Derive and Bank Human Induced Pluripotent Stem Cells
11. Exosome Diagnostics Presents Data Demonstrating Clinical Applications of Exosome Technology in Brain Cancer, Prostate Cancer, and Alzheimers Disease at the International Society for Extracellular Vesicles 2013 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... and VANCOUVER , July 2, ... (TSX-V: EPI) announced today that its common shares have been ... ("NASDAQ") under the symbol "EPIX". ESSA will begin ... retain its listing on the TSX Venture Exchange under the ... of the common shares on the NASDAQ, each of the ...
(Date:7/2/2015)... 2015 Releases of the genetically ... aegypti , , reduced the dengue mosquito population ... by 95%, well below the modelled threshold for ... The journal PLOS Neglected Tropical Diseases published ... engineered mosquitoes. The results showed that in Juazeiro city, ...
(Date:7/2/2015)...   EVO Aesthetic Center and Wellness Spa ... aesthetics in Lakeway, Texas and ... Astanza Duality laser. The medical spa is focused on ... and laser procedures. Their addition of the Astanza Duality ... to their tattoo regret. "The large number ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3EVO Offers Advanced Laser Tattoo Removal With Astanza Duality In Lakeway, TX 2
... Md., Oct. 15 EntreMed, Inc. (Nasdaq: ... therapeutics for the treatment of cancer, today announced ... NASDAQ Stock Market indicating that it has regained ... of Listed Securities ("MVLS") requirement for continued listing ...
... Cellectis (Alternext: ALCLS), the French genome engineering specialist, today ... June 30, 2010: revenues increased 25% over H1 2009, ... with euro 38 million in cash reserves. ... a number of important new agreements (with BASF Plant ...
Cached Medicine Technology:EntreMed Receives Notice of NASDAQ Compliance 2Cellectis Publishes Its Financial Statement for the First Half of 2010 2Cellectis Publishes Its Financial Statement for the First Half of 2010 3
(Date:7/2/2015)... ... July 02, 2015 , ... The American Association of Poison ... Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together with ... to decrease drug overdose – especially of heroin and opioid medication – by ...
(Date:7/2/2015)... ... , ... In 2012, Patrick Achebe realized that the gift of poetry was fully in him, ... his first poem, and three years later he was publishing an entire book of poetry. ... the world. "I have always believed that the best way to lift yourself up, is ...
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression innovator, ... socks designed for men. , For style that’s quick on its feet, men ... This is great news for men everywhere because a simple change in socks can ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... Emerging Healthcare Delivery Coalition met for the late June Web-based session, the speakers ... new reimbursement schemes and managing high-risk patients through coordinated care. , During the ...
(Date:7/2/2015)... ... July 02, 2015 , ... Facial plastic surgery is about ... is an art and science that goes into successful facial reconstruction and contouring. ... features and lives of more than 2,500 satisfied facelift and neck lift patients ...
Breaking Medicine News(10 mins):Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3
... women scheduled for gynecologic surgery to address noncancerous symptoms said ... about the effects of the procedure on their sex lives. ... be sterilized did express concern in this study that they ... though that surgery does not affect hormone levels. Among ...
... ... and technology with OPS, a new one-day event embracing the entire online advertising community. ... on September 30, 2010 in New York City. Sales drives revenue, but operations determines ... (PRWEB) ...
... all SSRIs, researchers say , MONDAY, April 12 (HealthDay ... antidepressants in raising a kid,s risk of suicidal thoughts, ... the U.S. Food and Drug Administration,s decision in 2004 ... for an increased suicidality risk in children and adolescents ...
... lesions in the process of intestinal type gastric cancer. ... lesions is still unclear, a few studies have investigated the ... intestinal metaplasia, but all of them are limited by their ... published on April 14, 2010 in the World Journal ...
... at the University of Liverpool have discovered that dangerous strains ... infected with HIV in Africa. Their research has ... can cause severe disease by invading cells in the ... them to evolve into more dangerous, multi-drug resistant strains over ...
... ... , ... New Jersey (PRWEB) April 12, 2010 -- Physicians, nurse practitioners, and physician assistants in ... are invited to attend “Recognizing and Treating Multiple Sclerosis in the Primary Care Setting,” ...
Cached Medicine News:Health News:Most women facing gynecologic surgery don't worry about its effects on sex 2Health News:Most women facing gynecologic surgery don't worry about its effects on sex 3Health News:Most women facing gynecologic surgery don't worry about its effects on sex 4Health News:AdMonsters Announces the Launch of OPS, to be Held on September 30, 2010 in New York 2Health News:AdMonsters Announces the Launch of OPS, to be Held on September 30, 2010 in New York 3Health News:Kids' Suicide Risk Same for All Antidepressants 2Health News:Kids' Suicide Risk Same for All Antidepressants 3Health News:Prevalence of HIV in Africa is leading to new strains of Salmonella, say scientists 2Health News:Free CME/CE Lecture and Workshop on Multiple Sclerosis: Boise, ID 2
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000) ...
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products. Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000), BinaxNow E.coli...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of antibodies to Treponema pallidum in human serum, plasma and whole blood specimens...
Medicine Products: